OSM and COVID-19: Arunachalam et al. proved that there were enhanced plasma levels of inflammatory mediators, including EN-RAGE, TNFSF 14, and oncostatin-M (OSM) in severe COVID-19 infected patients, which was correlated with disease severity and increased bacterial products [24].